The stem cell secretome and its role in brain repair

Biochimie

Volumn 95, Issue 12, 2013, Pages 2271-2285

  Drago, Denise ^a   Cossetti, Chiara ^b,c   Iraci, Nunzio ^b,c   Gaude, Edoardo ^a   Musco, Giovanna ^a   Bachi, Angela ^a   Pluchino, Stefano ^a,b,c  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Brain repair; Mesenchymal stem cells; Neural stem cells; Secretome; Stem cell transplantation

Indexed keywords

BEVACIZUMAB; BRAIN DERIVED NEUROTROPHIC FACTOR; CHEMOKINE RECEPTOR CXCR4; CYSTATIN C; FIBROBLAST GROWTH FACTOR 2; GALECTIN 1; HYPOCALCIN; INTERLEUKIN 10; INTERLEUKIN 6; LAMININ; NEUROMEDIN N; NEUROTENSIN; NEUROTROPHIN 3; NEUTROPHIL ACTIVATING PROTEIN 2; OSTEONECTIN; PIGMENT EPITHELIUM DERIVED FACTOR; PLATELET DERIVED GROWTH FACTOR AB; PROSTAGLANDIN E2; PROTEIN; SCATTER FACTOR; SEMAPHORIN 3A; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

BRAIN; CENTRAL NERVOUS SYSTEM DISEASE; CYTOLYSIS; HUMAN; IMMUNOCYTOCHEMISTRY; MEMBRANE VESICLE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NEUROPROTECTION; NONHUMAN; REVIEW; TRAUMATIC BRAIN INJURY;

HARNESS;

BRAIN REPAIR; MESENCHYMAL STEM CELLS; NEURAL STEM CELLS; SECRETOME; STEM CELL TRANSPLANTATION;

ANIMALS; BRAIN; CULTURE MEDIA, CONDITIONED; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MESENCHYMAL STROMAL CELLS; NERVE GROWTH FACTORS; PARACRINE COMMUNICATION; PROTEOME; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84887820815     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2013.06.020     Document Type: Review

References (204)

1. Y. Barhum, S. Gai-Castro, M. Bahat-Stromza, R. Barzilay, E. Melamed, and D. Offen Intracerebroventricular transplantation of human mesenchymal stem cells induced to secrete neurotrophic factors attenuates clinical symptoms in a mouse model of multiple sclerosis J. Mol. Neurosci. 41 2010 129 137
2. Z. Kokaia, G. Martino, M. Schwartz, and O. Lindvall Cross-talk between neural stem cells and immune cells: the key to better brain repair? Nat. Neurosci. 15 2012 1078 1087
3. S. Pluchino, L. Zanotti, E. Brambilla, P. Rovere-Querini, A. Capobianco, C. Alfaro-Cervello, G. Salani, C. Cossetti, G. Borsellino, L. Battistini, M. Ponzoni, C. Doglioni, J.M. Garcia-Verdugo, G. Comi, A.A. Manfredi, and G. Martino Immune regulatory neural stem/precursor cells protect from central nervous system autoimmunity by restraining dendritic cell function PLoS One 4 2009 e5959
4. M. Blurton-Jones, M. Kitazawa, H. Martinez-Coria, N.A. Castello, F.J. Muller, J.F. Loring, T.R. Yamasaki, W.W. Poon, K.N. Green, and F.M. LaFerla Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease Proc. Natl. Acad. Sci. U. S. A. 106 2009 13594 13599
5. M. Cusimano, D. Biziato, E. Brambilla, M. Donegà, C. Alfaro-Cervello, S. Snider, G. Salani, F. Pucci, G. Comi, J.M. Garcia-Verdugo, M. De Palma, G. Martino, and S. Pluchino Transplanted neural stem/precursor cells instruct phagocytes and reduce secondary tissue damage in the injured spinal cord Brain 135 2012 447 460
6. M. Bacigaluppi, S. Pluchino, L. Peruzzotti-Jametti, E. Kilic, U. Kilic, G. Salani, E. Brambilla, M.J. West, G. Comi, G. Martino, and D.M. Hermann Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms Brain 132 2009 2239 2251
7. S. Pluchino, L. Zanotti, B. Rossi, E. Brambilla, L. Ottoboni, G. Salani, M. Martinello, A. Cattalini, A. Bergami, R. Furlan, G. Comi, G. Constantin, and G. Martino Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism Nature 436 2005 266 271
8. A. Uccelli, A. Laroni, and M.S. Freedman Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases Lancet Neurol. 10 2011 649 656
9. S. Pluchino, and C. Cossetti How stem cells speak with host immune cells in inflammatory brain diseases Glia 2013
10. C. Cossetti, C. Alfaro-Cervello, M. Donega, G. Tyzack, and S. Pluchino New perspectives of tissue remodelling with neural stem and progenitor cell-based therapies Cell Tissue Res. 349 2012 321 329
11. J.S. Lees, E.S. Sena, K.J. Egan, A. Antonic, S.A. Koblar, D.W. Howells, and M.R. Macleod Stem cell-based therapy for experimental stroke: a systematic review and meta-analysis Int. J. Stroke 7 2012 582 588
12. D. De Feo, A. Merlini, C. Laterza, and G. Martino Neural stem cell transplantation in central nervous system disorders: from cell replacement to neuroprotection Curr. Opin. Neurol. 25 2012 322 333
13. S. Pluchino, and G. Martino The therapeutic plasticity of neural stem/precursor cells in multiple sclerosis J. Neurol. Sci. 265 2008 105 110
14. P.R. Baraniak, and T.C. McDevitt Stem cell paracrine actions and tissue regeneration Regen. Med. 5 2010 121 143
15. Y. Shi, J. Su, A.I. Roberts, P. Shou, A.B. Rabson, and G. Ren How mesenchymal stem cells interact with tissue immune responses Trends Immunol. 33 2012 136 143
16. N.B. Ivanova, J.T. Dimos, C. Schaniel, J.A. Hackney, K.A. Moore, and I.R. Lemischka A stem cell molecular signature Science 298 2002 601 604
17. C. Cossetti, J.A. Smith, N. Iraci, T. Leonardi, C. Alfaro-Cervello, and S. Pluchino Extracellular membrane vesicles and immune regulation in the brain Front Physiol. 3 2012 117
18. A.J. Friedenstein, U.F. Deriglasova, N.N. Kulagina, A.F. Panasuk, S.F. Rudakowa, E.A. Luria, and I.A. Ruadkow Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method Exp. Hematol. 2 1974 83 92
19. P.A. Zuk, M. Zhu, P. Ashjian, D.A. De Ugarte, J.I. Huang, H. Mizuno, Z.C. Alfonso, J.K. Fraser, P. Benhaim, and M.H. Hedrick Human adipose tissue is a source of multipotent stem cells Mol. Biol. Cell 13 2002 4279 4295
20. S. Shi, and S. Gronthos Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp J. Bone Miner. Res. 18 2003 696 704
21. M.H. Abumaree, M.A. Al Jumah, B. Kalionis, D. Jawdat, A. Al Khaldi, A.A. AlTalabani, and B.A. Knawy Phenotypic and functional characterization of mesenchymal stem cells from chorionic villi of human term placenta Stem Cell Rev. 9 2012 16 31
22. A. Erices, P. Conget, and J.J. Minguell Mesenchymal progenitor cells in human umbilical cord blood Br. J. Haematol. 109 2000 235 242
23. M.L. Weiss, and D.L. Troyer Stem cells in the umbilical cord Stem Cell Rev. 2 2006 155 162
24. M. Tome, S.L. Lindsay, J.S. Riddell, and S.C. Barnett Identification of nonepithelial multipotent cells in the embryonic olfactory mucosa Stem Cells 27 2009 2196 2208
25. M. Miura, S. Gronthos, M. Zhao, B. Lu, L.W. Fisher, P.G. Robey, and S. Shi SHED: stem cells from human exfoliated deciduous teeth Proc. Natl. Acad. Sci. U. S. A. 100 2003 5807 5812
26. P.S. in 't Anker, W.A. Noort, S.A. Scherjon, C. Kleijburg-van der Keur, A.B. Kruisselbrink, R.L. van Bezooijen, W. Beekhuizen, R. Willemze, H.H. Kanhai, and W.E. Fibbe Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential Haematologica 88 2003 845 852
27. G. Paul, I. Ozen, N.S. Christophersen, T. Reinbothe, J. Bengzon, E. Visse, K. Jansson, K. Dannaeus, C. Henriques-Oliveira, L. Roybon, S.V. Anisimov, E. Renstrom, M. Svensson, A. Haegerstrand, and P. Brundin The adult human brain harbors multipotent perivascular mesenchymal stem cells PLoS One 7 2012 e35577
28. M. Dominici, K. Le Blanc, I. Mueller, I. Slaper-Cortenbach, F. Marini, D. Krause, R. Deans, A. Keating, D. Prockop, and E. Horwitz Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement Cytotherapy 8 2006 315 317
29. S. Wang, X. Qu, and R.C. Zhao Mesenchymal stem cells hold promise for regenerative medicine Front. Med. 5 2011 372 378
30. D.J. Maltman, S.A. Hardy, and S.A. Przyborski Role of mesenchymal stem cells in neurogenesis and nervous system repair Neurochem. Int. 59 2011 347 356
31. A. Uccelli, F. Benvenuto, A. Laroni, and D. Giunti Neuroprotective features of mesenchymal stem cells, best practice & research Clin. Haematol. 24 2011 59 64
32. A. Uccelli, V. Pistoia, and L. Moretta Mesenchymal stem cells: a new strategy for immunosuppression? Trends Immunol. 28 2007 219 226
33. C.B. Ripoll, M. Flaat, J. Klopf-Eiermann, J.M. Fisher-Perkins, C.B. Trygg, B.A. Scruggs, M.L. McCants, H.P. Leonard, A.F. Lin, S. Zhang, M.E. Eagle, X. Alvarez, Y.T. Li, S.C. Li, J.M. Gimble, and B.A. Bunnell Mesenchymal lineage stem cells have pronounced anti-inflammatory effects in the twitcher mouse model of Krabbe's disease Stem Cells 29 2011 67 77
34. G. Constantin, S. Marconi, B. Rossi, S. Angiari, L. Calderan, E. Anghileri, B. Gini, S.D. Bach, M. Martinello, F. Bifari, M. Galie, E. Turano, S. Budui, A. Sbarbati, M. Krampera, and B. Bonetti Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis Stem Cells 2009
35. E. Gerdoni, B. Gallo, S. Casazza, S. Musio, I. Bonanni, E. Pedemonte, R. Mantegazza, F. Frassoni, G. Mancardi, R. Pedotti, and A. Uccelli Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis Ann. Neurol. 61 2007 219 227
36. E. Zappia, S. Casazza, E. Pedemonte, F. Benvenuto, I. Bonanni, E. Gerdoni, D. Giunti, A. Ceravolo, F. Cazzanti, F. Frassoni, G. Mancardi, and A. Uccelli Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy Blood 106 2005 1755 1761
37. J. Zhang, Y. Li, J. Chen, Y. Cui, M. Lu, S.B. Elias, J.B. Mitchell, L. Hammill, P. Vanguri, and M. Chopp Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice Exp. Neurol. 195 2005 16 26
38. J. Zhang, Y. Li, M. Lu, Y. Cui, J. Chen, L. Noffsinger, S.B. Elias, and M. Chopp Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis mice J. Neurosci. Res. 84 2006 587 595
39. L. Bai, D.P. Lennon, A.I. Caplan, A. DeChant, J. Hecker, J. Kranso, A. Zaremba, and R.H. Miller Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models Nat. Neurosci. 15 2012 862 870
40. A. Voulgari-Kokota, R. Fairless, M. Karamita, V. Kyrargyri, V. Tseveleki, M. Evangelidou, B. Delorme, P. Charbord, R. Diem, and L. Probert Mesenchymal stem cells protect CNS neurons against glutamate excitotoxicity by inhibiting glutamate receptor expression and function Exp. Neurol. 236 2012 161 170
41. M.B. Abrams, C. Dominguez, K. Pernold, R. Reger, Z. Wiesenfeld-Hallin, L. Olson, and D. Prockop Multipotent mesenchymal stromal cells attenuate chronic inflammation and injury-induced sensitivity to mechanical stimuli in experimental spinal cord injury Restor. Neurol. Neurosci. 27 2009 307 321
42. W. Gu, F. Zhang, Q. Xue, Z. Ma, P. Lu, and B. Yu Transplantation of bone marrow mesenchymal stem cells reduces lesion volume and induces axonal regrowth of injured spinal cord Neuropathology 30 2010 205 217
43. C.C. Yang, Y.H. Shih, M.H. Ko, S.Y. Hsu, H. Cheng, and Y.S. Fu Transplantation of human umbilical mesenchymal stem cells from Wharton's jelly after complete transection of the rat spinal cord PLoS One 3 2008 e3336
44. Y.T. Lin, Y. Chern, C.K. Shen, H.L. Wen, Y.C. Chang, H. Li, T.H. Cheng, and H.M. Hsieh-Li Human mesenchymal stem cells prolong survival and ameliorate motor deficit through trophic support in Huntington's disease mouse models PLoS One 6 2011 e22924
45. F. Wang, T. Yasuhara, T. Shingo, M. Kameda, N. Tajiri, W.J. Yuan, A. Kondo, T. Kadota, T. Baba, J.T. Tayra, Y. Kikuchi, Y. Miyoshi, and I. Date Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha BMC Neurosci. 11 2010 52
46. M.K. McCoy, T.N. Martinez, K.A. Ruhn, P.C. Wrage, E.W. Keefer, B.R. Botterman, K.E. Tansey, and M.G. Tansey Autologous transplants of Adipose-Derived Adult Stromal (ADAS) cells afford dopaminergic neuroprotection in a model of Parkinson's disease Exp. Neurol. 210 2008 14 29
47. K. Wakabayashi, A. Nagai, A.M. Sheikh, Y. Shiota, D. Narantuya, T. Watanabe, J. Masuda, S. Kobayashi, S.U. Kim, and S. Yamaguchi Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model J. Neurosci. Res. 88 2010 1017 1025
48. D.C. Ding, W.C. Shyu, M.F. Chiang, S.Z. Lin, Y.C. Chang, H.J. Wang, C.Y. Su, and H. Li Enhancement of neuroplasticity through upregulation of beta1-integrin in human umbilical cord-derived stromal cell implanted stroke model Neurobiol. Dis. 27 2007 339 353
49. J. Rehman, D. Traktuev, J. Li, S. Merfeld-Clauss, C.J. Temm-Grove, J.E. Bovenkerk, C.L. Pell, B.H. Johnstone, R.V. Considine, and K.L. March Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells Circulation 109 2004 1292 1298
50. A.J. Salgado, R.L. Reis, N.J. Sousa, and J.M. Gimble Adipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine Curr. Stem Cell Res. Ther. 5 2010 103 110
51. Y. Egashira, S. Sugitani, Y. Suzuki, K. Mishiro, K. Tsuruma, M. Shimazawa, S. Yoshimura, T. Iwama, and H. Hara The conditioned medium of murine and human adipose-derived stem cells exerts neuroprotective effects against experimental stroke model Brain Res. 1461 2012 87 95
52. X. Wei, Z. Du, L. Zhao, D. Feng, G. Wei, Y. He, J. Tan, W.H. Lee, H. Hampel, R. Dodel, B.H. Johnstone, K.L. March, M.R. Farlow, and Y. Du IFATS collection: the conditioned media of adipose stromal cells protect against hypoxia-ischemia-induced brain damage in neonatal rats Stem Cells 27 2009 478 488
53. L. Crigler, R.C. Robey, A. Asawachaicharn, D. Gaupp, and D.G. Phinney Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis Exp. Neurol. 198 2006 54 64
54. N. Nakano, Y. Nakai, T.B. Seo, Y. Yamada, T. Ohno, A. Yamanaka, Y. Nagai, M. Fukushima, Y. Suzuki, T. Nakatani, and C. Ide Characterization of conditioned medium of cultured bone marrow stromal cells Neurosci. Lett. 483 2010 57 61
55. A.J. Salgado, J.S. Fraga, A.R. Mesquita, N.M. Neves, R.L. Reis, and N. Sousa Role of human umbilical cord mesenchymal progenitors conditioned media in neuronal/glial cell densities, viability, and proliferation Stem Cells Dev. 19 2010 1067 1074
56. B. Tan, Z. Luan, X. Wei, Y. He, G. Wei, B.H. Johnstone, M. Farlow, and Y. Du AMP-activated kinase mediates adipose stem cell-stimulated neuritogenesis of PC12 cells Neuroscience 181 2011 40 47
57. L.T. Galindo, T.R. Filippo, P. Semedo, C.B. Ariza, C.M. Moreira, N.O. Camara, and M.A. Porcionatto Mesenchymal stem cell therapy modulates the inflammatory response in experimental traumatic brain injury Neurol. Res. Int. 2011 2011 564089
58. F.J. Rivera, M. Kandasamy, S. Couillard-Despres, M. Caioni, R. Sanchez, C. Huber, N. Weidner, U. Bogdahn, and L. Aigner Oligodendrogenesis of adult neural progenitors: differential effects of ciliary neurotrophic factor and mesenchymal stem cell derived factors J. Neurochem. 107 2008 832 843
59. M.M. Duffy, T. Ritter, R. Ceredig, and M.D. Griffin Mesenchymal stem cell effects on T-cell effector pathways Stem Cell Res. Ther. 2 2011 34
60. M. Franquesa, M.J. Hoogduijn, O. Bestard, and J.M. Grinyo Immunomodulatory effect of mesenchymal stem cells on B cells Front. Immunol. 3 2012 212
61. L. Raffaghello, G. Bianchi, M. Bertolotto, F. Montecucco, A. Busca, F. Dallegri, L. Ottonello, and V. Pistoia Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche Stem Cells 26 2008 151 162
62. G.M. Spaggiari, A. Capobianco, H. Abdelrazik, F. Becchetti, M.C. Mingari, and L. Moretta Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2 Blood 111 2008 1327 1333
63. E. Ivanova-Todorova, I. Bochev, M. Mourdjeva, R. Dimitrov, D. Bukarev, S. Kyurkchiev, P. Tivchev, I. Altunkova, and D.S. Kyurkchiev Adipose tissue-derived mesenchymal stem cells are more potent suppressors of dendritic cells differentiation compared to bone marrow-derived mesenchymal stem cells Immunol. Lett. 126 2009 37 42
64. S.J. Prasanna, D. Gopalakrishnan, S.R. Shankar, and A.B. Vasandan Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially PLoS One 5 2010 e9016
65. L. Bai, D.P. Lennon, V. Eaton, K. Maier, A.I. Caplan, S.D. Miller, and R.H. Miller Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis Glia 57 2009 1192 1203
66. G. Constantin, S. Marconi, B. Rossi, S. Angiari, L. Calderan, E. Anghileri, B. Gini, S.D. Bach, M. Martinello, F. Bifari, M. Galie, E. Turano, S. Budui, A. Sbarbati, M. Krampera, and B. Bonetti Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis Stem Cells 27 2009 2624 2635
67. D. Gordon, G. Pavlovska, C.P. Glover, J.B. Uney, D. Wraith, and N.J. Scolding Human mesenchymal stem cells abrogate experimental allergic encephalomyelitis after intraperitoneal injection, and with sparse CNS infiltration Neurosci. Lett. 448 2008 71 73
68. M. Rafei, E. Birman, K. Forner, and J. Galipeau Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitis Mol. Ther. 17 2009 1799 1803
69. M. Rafei, P.M. Campeau, A. Aguilar-Mahecha, M. Buchanan, P. Williams, E. Birman, S. Yuan, Y.K. Young, M.N. Boivin, K. Forner, M. Basik, and J. Galipeau Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner J. Immunol. 182 2009 5994 6002
70. N.L. Payne, G. Sun, C. McDonald, D. Layton, L. Moussa, A. Emerson-Webber, N. Veron, C. Siatskas, D. Herszfeld, J. Price, and C.C. Bernard Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination Cell Transplant. 2012 10.3727/096368912X657620 (Epub ahead of print)
71. Y. Jung, G. Bauer, and J.A. Nolta Concise review: induced pluripotent stem cell-derived mesenchymal stem cells: progress toward safe clinical products Stem Cells 30 2012 42 47
72. Q. Lian, Y. Zhang, J. Zhang, H.K. Zhang, X. Wu, F.F. Lam, S. Kang, J.C. Xia, W.H. Lai, K.W. Au, Y.Y. Chow, C.W. Siu, C.N. Lee, and H.F. Tse Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice Circulation 121 2010 1113 1123
73. E.J. Bassi, C.A. Aita, and N.O. Camara Immune regulatory properties of multipotent mesenchymal stromal cells: where do we stand? World J. Stem Cells 3 2011 1 8
74. F. Djouad, L.M. Charbonnier, C. Bouffi, P. Louis-Plence, C. Bony, F. Apparailly, C. Cantos, C. Jorgensen, and D. Noel Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism Stem Cells 25 2007 2025 2032
75. M. Matysiak, W. Orlowski, M. Fortak-Michalska, A. Jurewicz, and K. Selmaj Immunoregulatory function of bone marrow mesenchymal stem cells in EAE depends on their differentiation state and secretion of PGE2 J. Neuroimmunol. 233 2011 106 111
76. R. Meisel, A. Zibert, M. Laryea, U. Gobel, W. Daubener, and D. Dilloo Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation Blood 103 2004 4619 4621
77. J. Plumas, L. Chaperot, M.J. Richard, J.P. Molens, J.C. Bensa, and M.C. Favrot Mesenchymal stem cells induce apoptosis of activated T cells Leukemia 19 2005 1597 1604
78. G. Frumento, R. Rotondo, M. Tonetti, G. Damonte, U. Benatti, and G.B. Ferrara Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase J. Exp. Med. 196 2002 459 468
79. M. Platten, P.P. Ho, S. Youssef, P. Fontoura, H. Garren, E.M. Hur, R. Gupta, L.Y. Lee, B.A. Kidd, W.H. Robinson, R.A. Sobel, M.L. Selley, and L. Steinman Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite Science 310 2005 850 855
80. G.M. Spaggiari, H. Abdelrazik, F. Becchetti, and L. Moretta MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2 Blood 113 2009 6576 6583
81. M. Di Nicola, C. Carlo-Stella, M. Magni, M. Milanesi, P.D. Longoni, P. Matteucci, S. Grisanti, and A.M. Gianni Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli Blood 99 2002 3838 3843
82. A. Nasef, A. Chapel, C. Mazurier, S. Bouchet, M. Lopez, N. Mathieu, L. Sensebe, Y. Zhang, N.C. Gorin, D. Thierry, and L. Fouillard Identification of IL-10 and TGF-beta transcripts involved in the inhibition of T-lymphocyte proliferation during cell contact with human mesenchymal stem cells Gene Expr. 13 2007 217 226
83. B. Riteau, N. Rouas-Freiss, C. Menier, P. Paul, J. Dausset, and E.D. Carosella HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis J. Immunol. 166 2001 5018 5026
84. N. Lila, N. Rouas-Freiss, J. Dausset, A. Carpentier, and E.D. Carosella Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism Proc. Natl. Acad. Sci. U. S. A. 98 2001 12150 12155
85. V. Ristich, S. Liang, W. Zhang, J. Wu, and A. Horuzsko Tolerization of dendritic cells by HLA-G Eur. J. Immunol. 35 2005 1133 1142
86. Z. Selmani, A. Naji, I. Zidi, B. Favier, E. Gaiffe, L. Obert, C. Borg, P. Saas, P. Tiberghien, N. Rouas-Freiss, E.D. Carosella, and F. Deschaseaux Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+ CD25highFOXP3+ regulatory T cells Stem Cells 26 2008 212 222
87. Y. Lepelletier, S. Lecourt, A. Renand, B. Arnulf, V. Vanneaux, J.P. Fermand, P. Menasche, T. Domet, J.P. Marolleau, O. Hermine, and J. Larghero Galectin-1 and semaphorin-3A are two soluble factors conferring T-cell immunosuppression to bone marrow mesenchymal stem cell Stem Cells Dev. 19 2010 1075 1079
88. G. Martino, S. Pluchino, L. Bonfanti, and M. Schwartz Brain regeneration in physiology and pathology: the immune signature driving therapeutic plasticity of neural stem cells Physiol. Rev. 91 2011 1281 1304
89. T. Ben-Hur Immunomodulation by neural stem cells J. Neurol. Sci. 265 2008 102 104
90. B. Carletti, F. Piemonte, and F. Rossi Neuroprotection: the emerging concept of restorative neural stem cell biology for the treatment of neurodegenerative diseases Curr. Neuropharmacol. 9 2011 313 317
91. K. Chu, M. Kim, K.I. Park, S.W. Jeong, H.K. Park, K.H. Jung, S.T. Lee, L. Kang, K. Lee, D.K. Park, S.U. Kim, and J.K. Roh Human neural stem cells improve sensorimotor deficits in the adult rat brain with experimental focal ischemia Brain Res. 1016 2004 145 153
92. P. Lu, L.L. Jones, E.Y. Snyder, and M.H. Tuszynski Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury Exp. Neurol. 181 2003 115 129
93. D.E. Redmond Jr., K.B. Bjugstad, Y.D. Teng, V. Ourednik, J. Ourednik, D.R. Wakeman, X.H. Parsons, R. Gonzalez, B.C. Blanchard, S.U. Kim, Z. Gu, S.A. Lipton, E.A. Markakis, R.H. Roth, J.D. Elsworth, J.R. Sladek Jr., R.L. Sidman, and E.Y. Snyder Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells Proc. Natl. Acad. Sci. U. S. A. 104 2007 12175 12180
94. J.K. Ryu, J. Kim, S.J. Cho, K. Hatori, A. Nagai, H.B. Choi, M.C. Lee, J.G. McLarnon, and S.U. Kim Proactive transplantation of human neural stem cells prevents degeneration of striatal neurons in a rat model of Huntington disease Neurobiol. Dis. 16 2004 68 77
95. Y. Ziv, H. Avidan, S. Pluchino, G. Martino, and M. Schwartz Synergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injury Proc. Natl. Acad. Sci. U. S. A. 103 2006 13174 13179
96. R.H. Andres, N. Horie, W. Slikker, H. Keren-Gill, K. Zhan, G. Sun, N.C. Manley, M.P. Pereira, L.A. Sheikh, E.L. McMillan, B.T. Schaar, C.N. Svendsen, T.M. Bliss, and G.K. Steinberg Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain Brain 134 2011 1777 1789
97. T. Yasuhara, N. Matsukawa, K. Hara, G. Yu, L. Xu, M. Maki, S.U. Kim, and C.V. Borlongan Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson's disease J. Neurosci. 26 2006 12497 12511
98. J. Ourednik, V. Ourednik, W.P. Lynch, M. Schachner, and E.Y. Snyder Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons Nat. Biotechnol. 20 2002 1103 1110
99. S. Corti, F. Locatelli, D. Papadimitriou, R. Del Bo, M. Nizzardo, M. Nardini, C. Donadoni, S. Salani, F. Fortunato, S. Strazzer, N. Bresolin, and G.P. Comi Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model Brain 130 2007 1289 1305
100. S. Pluchino, A. Quattrini, E. Brambilla, A. Gritti, G. Salani, G. Dina, R. Galli, U. Del Carro, S. Amadio, A. Bergami, R. Furlan, G. Comi, A.L. Vescovi, and G. Martino Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis Nature 422 2003 688 694
101. O. Einstein, Y. Friedman-Levi, N. Grigoriadis, and T. Ben-Hur Transplanted neural precursors enhance host brain-derived myelin regeneration J. Neurosci. 29 2009 15694 15702
102. L. Madhavan, V. Ourednik, and J. Ourednik Neural stem/progenitor cells initiate the formation of cellular networks that provide neuroprotection by growth factor-modulated antioxidant expression Stem Cells 26 2008 254 265
103. H.C. Lim, S.T. Lee, K. Chu, K.M. Joo, L. Kang, W.S. Im, J.E. Park, S.U. Kim, M. Kim, and C.I. Cha Neuroprotective effect of neural stem cell-conditioned media in in vitro model of Huntington's disease Neurosci. Lett. 435 2008 175 180
104. J. Faijerson, A. Thorsell, J. Strandberg, E. Hanse, M. Sandberg, P.S. Eriksson, and R.B. Tinsley Adult neural stem/progenitor cells reduce NMDA-induced excitotoxicity via the novel neuroprotective peptide pentinin J. Neurochem. 109 2009 858 866
105. N. Horie, M.P. Pereira, K. Niizuma, G. Sun, H. Keren-Gill, A. Encarnacion, M. Shamloo, S.A. Hamilton, K. Jiang, S. Huhn, T.D. Palmer, T.M. Bliss, and G.K. Steinberg Transplanted stem cell-secreted VEGF effects post-stroke recovery, inflammation, and vascular repair Stem Cells 2011
106. Y.D. Teng, E.B. Lavik, X. Qu, K.I. Park, J. Ourednik, D. Zurakowski, R. Langer, and E.Y. Snyder Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells Proc. Natl. Acad. Sci. U. S. A. 99 2002 3024 3029
107. W. Cao, Y. Yang, Z. Wang, A. Liu, L. Fang, F. Wu, J. Hong, Y. Shi, S. Leung, C. Dong, and J.Z. Zhang Leukemia inhibitory factor inhibits T helper 17 cell differentiation and confers treatment effects of neural progenitor cell therapy in autoimmune disease Immunity 35 2011 273 284
108. L. Wang, J. Shi, F.W. van Ginkel, L. Lan, G. Niemeyer, D.R. Martin, E.Y. Snyder, and N.R. Cox Neural stem/progenitor cells modulate immune responses by suppressing T lymphocytes with nitric oxide and prostaglandin E2 Exp. Neurol. 216 2009 177 183
109. V. Bonnamain, E. Mathieux, R. Thinard, P. Thebault, V. Nerriere-Daguin, X. Leveque, I. Anegon, B. Vanhove, I. Neveu, and P. Naveilhan Expression of heme oxygenase-1 in neural stem/progenitor cells as a potential mechanism to evade host immune response Stem Cells 30 2012 2342 2353
110. G. Camussi, M.C. Deregibus, and V. Cantaluppi Role of stem-cell-derived microvesicles in the paracrine action of stem cells Biochem. Soc. Trans. 41 2013 283 287
111. L. Biancone, S. Bruno, M.C. Deregibus, C. Tetta, and G. Camussi Therapeutic potential of mesenchymal stem cell-derived microvesicles Nephrol. Dial. Transpl. 27 2012 3037 3042
112. G. Camussi, M.C. Deregibus, and C. Tetta Paracrine/endocrine mechanism of stem cells on kidney repair: role of microvesicle-mediated transfer of genetic information Curr. Opin. Nephrol. Hypertens. 19 2010 7 12
113. J. Ratajczak, M. Wysoczynski, F. Hayek, A. Janowska-Wieczorek, and M.Z. Ratajczak Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication Leukemia 20 2006 1487 1495
114. M.Z. Ratajczak, M. Kucia, T. Jadczyk, N.J. Greco, W. Wojakowski, M. Tendera, and J. Ratajczak Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies? Leukemia 26 2012 1166 1173
115. T.S. Chen, R.C. Lai, M.M. Lee, A.B. Choo, C.N. Lee, and S.K. Lim Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs Nucleic Acids Res. 38 2010 215 224
116. F. Collino, M.C. Deregibus, S. Bruno, L. Sterpone, G. Aghemo, L. Viltono, C. Tetta, and G. Camussi Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs PLoS One 5 2010 e11803
117. D.M. Pegtel, K. Cosmopoulos, D.A. Thorley-Lawson, M.A. van Eijndhoven, E.S. Hopmans, J.L. Lindenberg, T.D. de Gruijl, T. Wurdinger, and J.M. Middeldorp Functional delivery of viral miRNAs via exosomes Proc. Natl. Acad. Sci. U. S. A. 107 2010 6328 6333
118. H. Valadi, K. Ekstrom, A. Bossios, M. Sjostrand, J.J. Lee, and J.O. Lotvall Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells Nat. Cell Biol. 9 2007 654 659
119. R.C. Lai, S.S. Tan, B.J. Teh, S.K. Sze, F. Arslan, D.P. de Kleijn, A. Choo, and S.K. Lim Proteolytic potential of the MSC exosome proteome: implications for an exosome-mediated delivery of therapeutic proteasome Int. J. Proteomics 2012 2012 971907
120. H.S. Kim, D.Y. Choi, S.J. Yun, S.M. Choi, J.W. Kang, J.W. Jung, D. Hwang, K.P. Kim, and D.W. Kim Proteomic analysis of microvesicles derived from human mesenchymal stem cells J. Proteome Res. 11 2012 839 849
121. R.C. Lai, F. Arslan, M.M. Lee, N.S. Sze, A. Choo, T.S. Chen, M. Salto-Tellez, L. Timmers, C.N. Lee, R.M. El Oakley, G. Pasterkamp, D.P. de Kleijn, and S.K. Lim Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury Stem Cell Res. 4 2010 214 222
122. T. Katsuda, R. Tsuchiya, N. Kosaka, Y. Yoshioka, K. Takagaki, K. Oki, F. Takeshita, Y. Sakai, M. Kuroda, and T. Ochiya Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes Sci. Rep. 3 2013 1197
123. A. Mokarizadeh, N. Delirezh, A. Morshedi, G. Mosayebi, A.A. Farshid, and K. Mardani Microvesicles derived from mesenchymal stem cells: potent organelles for induction of tolerogenic signaling Immunol. Lett. 147 2012 47 54
124. S.Y. Kim, H.S. Cho, S.H. Yang, J.Y. Shin, J.S. Kim, and C.G. Park Exosomes secreted from human neural stem cell suppress T cell activation J. Immunol. 182 2009 90.33
125. S. Gatti, S. Bruno, M.C. Deregibus, A. Sordi, V. Cantaluppi, C. Tetta, and G. Camussi Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury Nephrol. Dial. Transpl. 26 2011 1474 1483
126. S. Roche, G. D'Ippolito, L.A. Gomez, T. Bouckenooghe, S. Lehmann, C.N. Montero-Menei, and P.C. Schiller Comparative analysis of protein expression of three stem cell populations: models of cytokine delivery system in vivo Int. J. Pharm. 440 2013 72 82
127. H. Skalnikova, J. Motlik, S.J. Gadher, and H. Kovarova Mapping of the secretome of primary isolates of mammalian cells, stem cells and derived cell lines Proteomics 11 2011 691 708
128. Y.A. Choi, J. Lim, K.M. Kim, B. Acharya, J.Y. Cho, Y.C. Bae, H.I. Shin, S.Y. Kim, and E.K. Park Secretome analysis of human BMSCs and identification of SMOC1 as an important ECM protein in osteoblast differentiation J. Proteome Res. 9 2010 2946 2956
129. R. Estrada, N. Li, H. Sarojini, J. An, M.J. Lee, and E. Wang Secretome from mesenchymal stem cells induces angiogenesis via Cyr61 J. Cell Physiol. 219 2009 563 571
130. J.M. Kim, J. Kim, Y.H. Kim, K.T. Kim, S.H. Ryu, T.G. Lee, and P.G. Suh Comparative secretome analysis of human bone marrow-derived mesenchymal stem cells during osteogenesis J. Cell Physiol. 228 2013 216 224
131. N. Li, H. Sarojini, J. An, and E. Wang Prosaposin in the secretome of marrow stroma-derived neural progenitor cells protects neural cells from apoptotic death J. Neurochem. 112 2010 1527 1538
132. C.H. Liu, and S.M. Hwang Cytokine interactions in mesenchymal stem cells from cord blood Cytokines 32 2005 270 279
133. H. Sarojini, R. Estrada, H. Lu, S. Dekova, M.J. Lee, R.D. Gray, and E. Wang PEDF from mouse mesenchymal stem cell secretome attracts fibroblasts J. Cell Biochem. 104 2008 1793 1802
134. R. Tasso, M. Gaetani, E. Molino, A. Cattaneo, M. Monticone, A. Bachi, and R. Cancedda The role of bFGF on the ability of MSC to activate endogenous regenerative mechanisms in an ectopic bone formation model Biomaterials 33 2012 2086 2096
135. S.K. Sze, D.P. de Kleijn, R.C. Lai, E. Khia Way Tan, H. Zhao, K.S. Yeo, T.Y. Low, Q. Lian, C.N. Lee, W. Mitchell, R.M. El Oakley, and S.K. Lim Elucidating the secretion proteome of human embryonic stem cell-derived mesenchymal stem cells Mol. Cell Proteomics 6 2007 1680 1689
136. A. Dahl, P.S. Eriksson, A.I. Persson, G. Karlsson, P. Davidsson, R. Ekman, and A. Westman-Brinkmalm Proteome analysis of conditioned medium from cultured adult hippocampal progenitors Rapid Commun. Mass Spectrom. 17 2003 2195 2202
137. H. Skalnikova, P. Vodicka, S.J. Gadher, and H. Kovarova Proteomics of neural stem cells Expert Rev. Proteomics 5 2008 175 186
138. D. Schubert, F. Herrera, R. Cumming, J. Read, W. Low, P. Maher, and W.H. Fischer Neural cells secrete a unique repertoire of proteins J. Neurochem. 109 2009 427 435
139. C. Griffoni, S. Di Molfetta, L. Fantozzi, C. Zanetti, P. Pippia, V. Tomasi, and E. Spisni Modification of proteins secreted by endothelial cells during modeled low gravity exposure J. Cell Biochem. 112 2011 265 272
140. K. Eichelbaum, M. Winter, M.B. Diaz, S. Herzig, and J. Krijgsveld Selective enrichment of newly synthesized proteins for quantitative secretome analysis Nat. Biotechnol. 30 2012 984 990
141. C.A. Ribeiro, J.S. Fraga, M. Graos, N.M. Neves, R.L. Reis, J.M. Gimble, N. Sousa, and A.J. Salgado The secretome of stem cells isolated from the adipose tissue and Wharton jelly acts differently on central nervous system derived cell populations Stem Cell Res. Ther. 3 2012 18
142. R. Kaddurah-Daouk, and K.R. Krishnan Metabolomics: a global biochemical approach to the study of central nervous system diseases Neuropsychopharmacology 34 2009 173 186
143. G.G. Cezar, J.A. Quam, A.M. Smith, G.J. Rosa, M.S. Piekarczyk, J.F. Brown, F.H. Gage, and A.R. Muotri Identification of small molecules from human embryonic stem cells using metabolomics Stem Cells Dev. 16 2007 869 882
144. L.E. McNamara, T. Sjostrom, R.M. Meek, R.O. Oreffo, B. Su, M.J. Dalby, and K.E. Burgess Metabolomics: a valuable tool for stem cell monitoring in regenerative medicine J. R. Soc. Interface 9 2012 1713 1724
145. A. Oskowitz, H. McFerrin, M. Gutschow, M.L. Carter, and R. Pochampally Serum-deprived human multipotent mesenchymal stromal cells (MSCs) are highly angiogenic Stem Cell Res. 6 2011 215 225
146. F.R. Sharp, R. Ran, A. Lu, Y. Tang, K.I. Strauss, T. Glass, T. Ardizzone, and M. Bernaudin Hypoxic preconditioning protects against ischemic brain injury NeuroRx 1 2004 26 35
147. C.P. Chang, C.C. Chio, C.U. Cheong, C.M. Chao, B.C. Cheng, and M.T. Lin Hypoxic preconditioning enhances the therapeutic potential of the secretome from cultured human mesenchymal stem cells in experimental traumatic brain injury Clin. Sci. (Lond.) 124 2013 165 176
148. G. Ren, L. Zhang, X. Zhao, G. Xu, Y. Zhang, A.I. Roberts, R.C. Zhao, and Y. Shi Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide Cell Stem Cell 2 2008 141 150
149. D. Polchert, J. Sobinsky, G. Douglas, M. Kidd, A. Moadsiri, E. Reina, K. Genrich, S. Mehrotra, S. Setty, B. Smith, and A. Bartholomew IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease Eur. J. Immunol. 38 2008 1745 1755
150. M. Krampera Mesenchymal stromal cell 'licensing': a multistep process Leukemia 25 2011 1408 1414
151. H. Yagi, A. Soto-Gutierrez, N. Navarro-Alvarez, Y. Nahmias, Y. Goldwasser, Y. Kitagawa, A.W. Tilles, R.G. Tompkins, B. Parekkadan, and M.L. Yarmush Reactive bone marrow stromal cells attenuate systemic inflammation via sTNFR1 Mol. Ther. 18 2010 1857 1864
152. H. Sakata, P. Narasimhan, K. Niizuma, C.M. Maier, T. Wakai, and P.H. Chan Interleukin 6-preconditioned neural stem cells reduce ischaemic injury in stroke mice Brain 135 2012 3298 3310
153. T.J. Bartosh, J.H. Ylostalo, A. Mohammadipoor, N. Bazhanov, K. Coble, K. Claypool, R.H. Lee, H. Choi, and D.J. Prockop Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties Proc. Natl. Acad. Sci. U. S. A. 107 2010 13724 13729
154. J.E. Frith, B. Thomson, and P.G. Genever Dynamic three-dimensional culture methods enhance mesenchymal stem cell properties and increase therapeutic potential Tissue Eng. Part C Methods 16 2010 735 749
155. N.D. Dey, M.C. Bombard, B.P. Roland, S. Davidson, M. Lu, J. Rossignol, M.I. Sandstrom, R.L. Skeel, L. Lescaudron, and G.L. Dunbar Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington's disease Behav. Brain Res. 214 2010 193 200
156. S.D. Olson, K. Pollock, A. Kambal, W. Cary, G.M. Mitchell, J. Tempkin, H. Stewart, J. McGee, G. Bauer, H.S. Kim, T. Tempkin, V. Wheelock, G. Annett, G. Dunbar, and J.A. Nolta Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington's disease Mol. Neurobiol. 45 2012 87 98
157. E. Perez-Navarro, J. Alberch, E. Arenas, N. Calvo, and J. Marsal Nerve growth factor and basic fibroblast growth factor protect cholinergic neurons against quinolinic acid excitotoxicity in rat neostriatum Eur. J. Neurosci. 6 1994 706 711
158. K. Kurozumi, K. Nakamura, T. Tamiya, Y. Kawano, M. Kobune, S. Hirai, H. Uchida, K. Sasaki, Y. Ito, K. Kato, O. Honmou, K. Houkin, I. Date, and H. Hamada BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model Mol. Ther. 9 2004 189 197
159. Y. Miki, N. Nonoguchi, N. Ikeda, R.S. Coffin, T. Kuroiwa, and S. Miyatake Vascular endothelial growth factor gene-transferred bone marrow stromal cells engineered with a herpes simplex virus type 1 vector can improve neurological deficits and reduce infarction volume in rat brain ischemia Neurosurgery 61 2007 586 594 Discussion 594-585
160. N. Xiong, Z. Zhang, J. Huang, C. Chen, M. Jia, J. Xiong, X. Liu, F. Wang, X. Cao, Z. Liang, S. Sun, Z. Lin, and T. Wang VEGF-expressing human umbilical cord mesenchymal stem cells, an improved therapy strategy for Parkinson's disease Gene Ther. 18 2011 394 402
161. A. Bakshi, S. Shimizu, C.A. Keck, S. Cho, D.G. LeBold, D. Morales, E. Arenas, E.Y. Snyder, D.J. Watson, and T.K. McIntosh Neural progenitor cells engineered to secrete GDNF show enhanced survival, neuronal differentiation and improve cognitive function following traumatic brain injury Eur. J. Neurosci. 23 2006 2119 2134
162. H.J. Lee, K.S. Kim, I.H. Park, and S.U. Kim Human neural stem cells over-expressing VEGF provide neuroprotection, angiogenesis and functional recovery in mouse stroke model PLoS One 2 2007 e156
163. M. Sakaguchi, T. Shingo, T. Shimazaki, H.J. Okano, M. Shiwa, S. Ishibashi, H. Oguro, M. Ninomiya, T. Kadoya, H. Horie, A. Shibuya, H. Mizusawa, F. Poirier, H. Nakauchi, K. Sawamoto, and H. Okano A carbohydrate-binding protein, Galectin-1, promotes proliferation of adult neural stem cells Proc. Natl. Acad. Sci. U. S. A. 103 2006 7112 7117
164. Y. Imaizumi, M. Sakaguchi, T. Morishita, M. Ito, F. Poirier, K. Sawamoto, and H. Okano Galectin-1 is expressed in early-type neural progenitor cells and down-regulates neurogenesis in the adult hippocampus Mol. Brain 4 2011 7
165. W.S. Qu, Y.H. Wang, J.F. Ma, D.S. Tian, Q. Zhang, D.J. Pan, Z.Y. Yu, M.J. Xie, J.P. Wang, and W. Wang Galectin-1 attenuates astrogliosis-associated injuries and improves recovery of rats following focal cerebral ischemia J. Neurochem. 116 2011 217 226
166. J. Wang, Z.H. Lu, H.J. Gabius, C. Rohowsky-Kochan, R.W. Ledeen, and G. Wu Cross-linking of GM1 ganglioside by galectin-1 mediates regulatory T cell activity involving TRPC5 channel activation: possible role in suppressing experimental autoimmune encephalomyelitis J. Immunol. 182 2009 4036 4045
167. J. Yamane, M. Nakamura, A. Iwanami, M. Sakaguchi, H. Katoh, M. Yamada, S. Momoshima, S. Miyao, K. Ishii, N. Tamaoki, T. Nomura, H.J. Okano, Y. Kanemura, Y. Toyama, and H. Okano Transplantation of galectin-1-expressing human neural stem cells into the injured spinal cord of adult common marmosets J. Neurosci. Res. 88 2010 1394 1405
168. J. Yamane, S. Ishibashi, M. Sakaguchi, T. Kuroiwa, Y. Kanemura, M. Nakamura, H. Miyoshi, K. Sawamoto, Y. Toyama, H. Mizusawa, and H. Okano Transplantation of human neural stem/progenitor cells overexpressing galectin-1 improves functional recovery from focal brain ischemia in the Mongolian gerbil Mol. Brain 4 2011 35
169. J.L. Croxford, M. Feldmann, Y. Chernajovsky, and D. Baker Different therapeutic outcomes in experimental allergic encephalomyelitis dependent upon the mode of delivery of IL-10: a comparison of the effects of protein, adenoviral or retroviral IL-10 delivery into the central nervous system J. Immunol. 166 2001 4124 4130
170. J. Yang, Z. Jiang, D.C. Fitzgerald, C. Ma, S. Yu, H. Li, Z. Zhao, Y. Li, B. Ciric, M. Curtis, A. Rostami, and G.X. Zhang Adult neural stem cells expressing IL-10 confer potent immunomodulation and remyelination in experimental autoimmune encephalitis J. Clin. Investig. 119 2009 3678 3691
171. M. Neri, A. Ricca, I. di Girolamo, B. Alcala'-Franco, C. Cavazzin, A. Orlacchio, S. Martino, L. Naldini, and A. Gritti Neural stem cell gene therapy ameliorates pathology and function in a mouse model of globoid cell leukodystrophy Stem Cells 29 2011 1559 1571
172. G.W. Hawryluk, A. Mothe, J. Wang, S. Wang, C. Tator, and M.G. Fehlings An in vivo characterization of trophic factor production following neural precursor cell or bone marrow stromal cell transplantation for spinal cord injury Stem Cells Dev. 21 2012 2222 2238
173. N. Zilka, M. Zilkova, Z. Kazmerova, M. Sarissky, V. Cigankova, and M. Novak Mesenchymal stem cells rescue the Alzheimer's disease cell model from cell death induced by misfolded truncated tau Neuroscience 193 2011 330 337
174. B.E. Deverman, and P.H. Patterson Exogenous leukemia inhibitory factor stimulates oligodendrocyte progenitor cell proliferation and enhances hippocampal remyelination J. Neurosci. 32 2012 2100 2109
175. N. Beohar, J. Rapp, S. Pandya, and D.W. Losordo Rebuilding the damaged heart: the potential of cytokines and growth factors in the treatment of ischemic heart disease J. Am. Coll. Cardiol. 56 2010 1287 1297
176. P.A. Calabresi, N.S. Fields, H.W. Maloni, A. Hanham, J. Carlino, J. Moore, M.C. Levin, S. Dhib-Jalbut, L.R. Tranquill, H. Austin, H.F. McFarland, and M.K. Racke Phase 1 trial of transforming growth factor beta 2 in chronic progressive MS Neurology 51 1998 289 292
177. F. Mashayekhi, and L. Gholizadeh Administration of hepatocyte growth factor increases reelin and disabled 1 expression in the mouse cerebral cortex: an in vivo study Cell Mol. Neurobiol. 31 2011 1267 1270
178. N. Tsuzuki, T. Miyazawa, K. Matsumoto, T. Nakamura, and K. Shima Hepatocyte growth factor reduces the infarct volume after transient focal cerebral ischemia in rats Neurol. Res. 23 2001 417 424
179. J.G. Nutt, K.J. Burchiel, C.L. Comella, J. Jankovic, A.E. Lang, E.R. Laws Jr., A.M. Lozano, R.D. Penn, R.K. Simpson Jr., M. Stacy, and G.F. Wooten Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD Neurology 60 2003 69 73
180. S.S. Gill, N.K. Patel, G.R. Hotton, K. O'Sullivan, R. McCarter, M. Bunnage, D.J. Brooks, C.N. Svendsen, and P. Heywood Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease Nat. Med. 9 2003 589 595
181. J.T. Slevin, D.M. Gash, C.D. Smith, G.A. Gerhardt, R. Kryscio, H. Chebrolu, A. Walton, R. Wagner, and A.B. Young Unilateral intraputaminal glial cell line-derived neurotrophic factor in patients with Parkinson disease: response to 1 year each of treatment and withdrawal Neurosurg. Focus 20 2006 E1
182. S.J. Allen, J.J. Watson, D.K. Shoemark, N.U. Barua, and N.K. Patel GDNF, NGF and BDNF as therapeutic options for neurodegeneration Pharmacol. Ther. 138 2013 155 175
183. L. Tian, R. Guo, X. Yue, Q. Lv, X. Ye, Z. Wang, Z. Chen, B. Wu, G. Xu, and X. Liu Intranasal administration of nerve growth factor ameliorate beta-amyloid deposition after traumatic brain injury in rats Brain Res. 1440 2012 47 55
184. M.H. Tuszynski, L. Thal, M. Pay, D.P. Salmon, H.S. U, R. Bakay, P. Patel, A. Blesch, H.L. Vahlsing, G. Ho, G. Tong, S.G. Potkin, J. Fallon, L. Hansen, E.J. Mufson, J.H. Kordower, C. Gall, and J. Conner A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease Nat. Med. 11 2005 551 555
185. K.M. Bishop, E.K. Hofer, A. Mehta, A. Ramirez, L. Sun, M. Tuszynski, and R.T. Bartus Therapeutic potential of CERE-110 (AAV2-NGF): targeted, stable, and sustained NGF delivery and trophic activity on rodent basal forebrain cholinergic neurons Exp. Neurol. 211 2008 574 584
186. C.A. Ribeiro, A.J. Salgado, J.S. Fraga, N.A. Silva, R.L. Reis, and N. Sousa The secretome of bone marrow mesenchymal stem cells-conditioned media varies with time and drives a distinct effect on mature neurons and glial cells (primary cultures) J. Tissue Eng. Regen. Med. 5 2011 668 672
187. F.G. Teixeira, M.M. Carvalho, N. Sousa, and A.J. Salgado Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration? Cell Mol. Life Sci. 2013
188. S. Koutsopoulos, L.D. Unsworth, Y. Nagai, and S. Zhang Controlled release of functional proteins through designer self-assembling peptide nanofiber hydrogel scaffold Proc. Natl. Acad. Sci. U. S. A. 106 2009 4623 4628
189. Y. Wang, E. Bakota, B.H. Chang, M. Entman, J.D. Hartgerink, and F.R. Danesh Peptide nanofibers preconditioned with stem cell secretome are renoprotective J. Am. Soc. Nephrol. 22 2011 704 717
190. E.L. Bakota, Y. Wang, F.R. Danesh, and J.D. Hartgerink Injectable multidomain peptide nanofiber hydrogel as a delivery agent for stem cell secretome Biomacromolecules 12 2011 1651 1657
191. L. Alvarez-Erviti, Y. Seow, H. Yin, C. Betts, S. Lakhal, and M.J. Wood Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes Nat. Biotechnol. 29 2011 341 345
192. P.J. Quesenberry, M.S. Dooner, and J.M. Aliotta Stem cell plasticity revisited: the continuum marrow model and phenotypic changes mediated by microvesicles Exp. Hematol. 38 2010 581 592
193. K. Aboody, A. Capela, N. Niazi, J.H. Stern, and S. Temple Translating stem cell studies to the clinic for CNS repair: current state of the art and the need for a Rosetta stone Neuron 70 2011 597 613
194. E. Giusto, M. Donega, C. Cossetti, and S. Pluchino Neuro-immune interactions of neural stem cell transplants: from animal disease models to human trials Exp. Neurol. 2013
195. S. Karamouzian, S.N. Nematollahi-Mahani, N. Nakhaee, and H. Eskandary Clinical safety and primary efficacy of bone marrow mesenchymal cell transplantation in subacute spinal cord injured patients Clin. Neurol. Neurosurg. 114 2012 935 939
196. S.D. Olson, A. Kambal, K. Pollock, G.M. Mitchell, H. Stewart, S. Kalomoiris, W. Cary, C. Nacey, K. Pepper, and J.A. Nolta Examination of mesenchymal stem cell-mediated RNAi transfer to Huntington's disease affected neuronal cells for reduction of huntingtin Mol. Cell Neurosci. 49 2012 271 281
197. A. Laroni, G. Novi, N. Kerlero de Rosbo, and A. Uccelli Towards clinical application of mesenchymal stem cells for treatment of neurological diseases of the central nervous system J. Neuroimmune Pharmacol. 2013
198. M. Cavazzana-Calvo, E. Payen, O. Negre, G. Wang, K. Hehir, F. Fusil, J. Down, M. Denaro, T. Brady, K. Westerman, R. Cavallesco, B. Gillet-Legrand, L. Caccavelli, R. Sgarra, L. Maouche-Chretien, F. Bernaudin, R. Girot, R. Dorazio, G.J. Mulder, A. Polack, A. Bank, J. Soulier, J. Larghero, N. Kabbara, B. Dalle, B. Gourmel, G. Socie, S. Chretien, N. Cartier, P. Aubourg, A. Fischer, K. Cornetta, F. Galacteros, Y. Beuzard, E. Gluckman, F. Bushman, S. Hacein-Bey-Abina, and P. Leboulch Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia Nature 467 2010 318 322
199. R. Ramos-Zuniga, O. Gonzalez-Perez, A. Macias-Ornelas, V. Capilla-Gonzalez, and A. Quinones-Hinojosa Ethical implications in the use of embryonic and adult neural stem cells Stem Cells Int. 2012 2012 470949
200. S. Schu, M. Nosov, L. O'Flynn, G. Shaw, O. Treacy, F. Barry, M. Murphy, T. O'Brien, and T. Ritter Immunogenicity of allogeneic mesenchymal stem cells J. Cell Mol. Med. 16 2012 2094 2103
201. M. Thier, P. Worsdorfer, Y.B. Lakes, R. Gorris, S. Herms, T. Opitz, D. Seiferling, T. Quandel, P. Hoffmann, M.M. Nothen, O. Brustle, and F. Edenhofer Direct conversion of fibroblasts into stably expandable neural stem cells Cell Stem Cell 10 2012 473 479
202. G.H. Liu, F. Yi, K. Suzuki, J. Qu, and J.C. Izpisua Belmonte Induced neural stem cells: a new tool for studying neural development and neurological disorders Cell Res. 22 2012 1087 1091
203. H. Okano, M. Nakamura, K. Yoshida, Y. Okada, O. Tsuji, S. Nori, E. Ikeda, S. Yamanaka, and K. Miura Steps toward safe cell therapy using induced pluripotent stem cells Circ. Res. 112 2013 523 533
204. S.H. Ranganath, O. Levy, M.S. Inamdar, and J.M. Karp Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease Cell Stem Cell 10 2012 244 258